Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: Randomized, double-blind, placebo-controlled Phase I studies

We report the findings of three randomized, double-blind, placebo-controlled Phase I studies undertaken to support licensure of the liquid formulation of the human G1P[8] rotavirus (RV) vaccine (RIX4414; GlaxoSmithKline Biologicals SA) in China. Healthy adults aged 18–45 y (n = 48) and children aged...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Li, Rong-Cheng, Li, Yan-Ping, Mo, Zhao-Jun, Luo, Dong, Huang, Teng, Kong, Ji-Lian, Wang, Lao-Hong, Song, Ning-Sheng, Liu, Aixue, Zhang, Helen, Liao, Xueyan, Karkada, Naveen, Han, Htay Htay
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2013
Assuntos:
Short Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3906260/
https://ncbi.nlm.nih.gov/pubmed/23807360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.25076
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados